The New England Journal of Medicine (NEJM) has published the results of a phase 2 trial (known as CENTAUR) of the compound AMX0035, produced by Amylyx, a Massachusetts-based pharmaceutical company. The results of the trial were very promising – people with ALS...
Paul and Kathy Tavano are no strangers to ALS. In August of 2009, Paul was diagnosed after having symptoms of weakness in his hands and muscle spasms. When he and his family heard the projected lifespan of 2-5 years after an ALS diagnosis, and how there was nothing...
ALS is a devastating disease, and as it progresses people lose the ability to walk, speak, move, and breathe. Here at the ALS Association of Texas, one of our most important initiatives is our Equipment Loan Program. This program allows our ALS community access to...
Emergencies and disasters can strike quickly and without warning. For the thousands of Americans living with ALS, emergencies such as fires, floods, and acts of nature present a real challenge. It is critical that people with ALS and their family members be proactive...
ALS is an expensive disease, and one of the biggest expenses people face is the cost of medical equipment. The ALS Association’s Equipment Loan Program alleviates this financial burden by providing equipment to people with ALS for free. COVID-19 has prevented ALS...
